Byrn is a dormant shell company with no operations or revenue. Its sole activity is maintaining SEC reporting obligations while its CEO and only employee, David Lazar, searches for a reverse merger target. Byrn was originally incorporated in 2011 as a healthcare IT company, went dormant in 2013, was revived under court-appointed custodianship in 2019, and has been dormant since a brief and voided share exchange attempt in 2021. The company changed its name to Byrn in 2024. Byrn's stated plan is to identify an acquisition target and execute a reverse merger, which would involve issuing a controlling block of shares to the target company's shareholders and likely raising additional capital. Until such a transaction occurs, Byrn has no path to revenue. The company incurs only minimal expenses, primarily related-party administrative fees paid to Lazar, who funds Byrn through interest-free demand loans. Lazar operates through Custodian Ventures and has taken custodianship of numerous distressed shell companies, with Byrn being one of many in his portfolio.